drugset / Trial / NCT01614431

N Acetyl Cysteine for Cystinosis Patients

NCT01614431

NaSingle-groupOpen-labelTreatment

Summary

This study intends to verify the interference of N acetyl cysteine in the progression of chronic kidney disease in patients with Nephropathic Cystinosis.

Timeline

Start
2011-03
Primary completion
2012-01
Completion
2012-05

Drugs

EvaluationDrugModalityDoseRoute
Subject N-acetylcysteine Small molecule